Insulet PE Ratio 2010-2024 | PODD
Current and historical p/e ratio for Insulet (PODD) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Insulet PE ratio as of April 07, 2025 is 85.13.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Insulet PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-04-04 | 245.26 | 42.36 | |
| 2024-12-31 | 261.07 | $5.79 | 45.09 |
| 2024-09-30 | 232.75 | $5.84 | 39.85 |
| 2024-06-30 | 201.80 | $5.50 | 36.69 |
| 2024-03-31 | 171.40 | $3.30 | 51.94 |
| 2023-12-31 | 216.98 | $2.91 | 74.56 |
| 2023-09-30 | 159.49 | $1.71 | 93.27 |
| 2023-06-30 | 288.34 | $0.89 | 323.98 |
| 2023-03-31 | 318.96 | $0.00 | 0.00 |
| 2022-12-31 | 294.39 | $0.06 | 4906.50 |
| 2022-09-30 | 229.40 | $0.24 | 955.83 |
| 2022-06-30 | 217.94 | $0.50 | 435.88 |
| 2022-03-31 | 266.39 | $0.63 | 422.84 |
| 2021-12-31 | 266.07 | $0.23 | 1156.83 |
| 2021-09-30 | 284.23 | $-0.45 | 0.00 |
| 2021-06-30 | 274.51 | $-0.46 | 0.00 |
| 2021-03-31 | 260.92 | $0.13 | 2007.08 |
| 2020-12-31 | 255.63 | $0.10 | 2556.30 |
| 2020-09-30 | 236.59 | $0.44 | 537.70 |
| 2020-06-30 | 194.26 | $0.28 | 693.79 |
| 2020-03-31 | 165.68 | $0.08 | 2071.00 |
| 2019-12-31 | 171.20 | $0.18 | 951.11 |
| 2019-09-30 | 164.93 | $0.26 | 634.35 |
| 2019-06-30 | 119.38 | $0.28 | 426.36 |
| 2019-03-31 | 95.09 | $0.23 | 413.43 |
| 2018-12-31 | 79.32 | $0.05 | 1586.40 |
| 2018-09-30 | 105.95 | $-0.23 | 0.00 |
| 2018-06-30 | 85.70 | $-0.30 | 0.00 |
| 2018-03-31 | 86.68 | $-0.40 | 0.00 |
| 2017-12-31 | 69.00 | $-0.46 | 0.00 |
| 2017-09-30 | 55.08 | $-0.50 | 0.00 |
| 2017-06-30 | 51.31 | $-0.51 | 0.00 |
| 2017-03-31 | 43.09 | $-0.46 | 0.00 |
| 2016-12-31 | 37.68 | $-0.51 | 0.00 |
| 2016-09-30 | 40.94 | $-0.83 | 0.00 |
| 2016-06-30 | 30.24 | $-1.11 | 0.00 |
| 2016-03-31 | 33.16 | $-1.30 | 0.00 |
| 2015-12-31 | 37.81 | $-1.29 | 0.00 |
| 2015-09-30 | 25.91 | $-0.91 | 0.00 |
| 2015-06-30 | 30.99 | $-0.77 | 0.00 |
| 2015-03-31 | 33.35 | $-1.03 | 0.00 |
| 2014-12-31 | 46.06 | $-0.93 | 0.00 |
| 2014-09-30 | 36.85 | $-0.87 | 0.00 |
| 2014-06-30 | 39.67 | $-1.07 | 0.00 |
| 2014-03-31 | 47.42 | $-0.74 | 0.00 |
| 2013-12-31 | 37.10 | $-0.83 | 0.00 |
| 2013-09-30 | 36.24 | $-1.00 | 0.00 |
| 2013-06-30 | 31.41 | $-0.87 | 0.00 |
| 2013-03-31 | 25.86 | $-0.97 | 0.00 |
| 2012-12-31 | 21.22 | $-1.08 | 0.00 |
| 2012-09-30 | 21.58 | $-1.17 | 0.00 |
| 2012-06-30 | 21.37 | $-1.20 | 0.00 |
| 2012-03-31 | 19.14 | $-1.32 | 0.00 |
| 2011-12-31 | 18.83 | $-1.23 | 0.00 |
| 2011-09-30 | 15.26 | $-1.43 | 0.00 |
| 2011-06-30 | 22.17 | $-1.44 | 0.00 |
| 2011-03-31 | 20.62 | $-1.38 | 0.00 |
| 2010-12-31 | 15.50 | $-1.53 | 0.00 |
| 2010-09-30 | 14.14 | $-1.45 | 0.00 |
| 2010-06-30 | 15.05 | $-2.03 | 0.00 |
| 2010-03-31 | 15.09 | $-2.40 | 0.00 |
| 2009-12-31 | 14.28 | $-2.74 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $19.908B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Medtronic (MDT) | Ireland | $115.624B | 16.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |